Roy Chowdhury, Shreya, PhD

Postdoc Fellow – Dr. Ling Wang’s Lab

(414) 955-2310

Research

Title: SNRK-Mediated Metabolic Reprogramming plays a Crucial Role int he Initial Stages of Ovarian Cancer Metastasis

Presentation
MCW Cancer Retreat on Friday, April 26, 2019
Award
Best Basic Science Poster

“SNRK-Mediated Metabolic Reprogramming plays a Crucial Role int he Initial Stages of Ovarian Cancer Metastasis”Dr. Roy Chowdhury received her PhD from Indian Institute of Chemical Biology , Kolkata, India. She joined Dr. Bishop’s laboratory in the Department of Obstetrics and Gynecology in July 2018.

She is interested in exploring the molecular mechanisms that discriminate primary from metastatic tumors. Her model is ovarian cancer. This disease in mostly found to metastasize to the omental fat in the abdomen, where the adipocytes aids the process of tumor development. She hypothesizes that expression patterns of key molecular players and metabolic alterations in the tumor-microenvironment assist in promoting ovarian cancer metastasis. Her primary goal is to ascertain the role of SNRK, am AMPK-related protein kinase in mediating adipocyte-induced ovarian cancer metastasis. If established, SNRK will be an exciting new target for combating ovarian cancer.